Daniel Vasella News
Most Popular Daniel Vasella Story
Novartis' Daniel Vasella - CEO Pay
Daniel Vasella- Novartis Total Compensation: $15.5M 2006 Revenue: $38.1B2007 Revenue: $39.8BChange: 4.46% Details: Vasella earned 17 million Swiss francs, or about $15.5M in 2007. That's down from... Read more...
Latest Headlines
- February 4, 2010
- February 1, 2010
- January 27, 2010
- January 26, 2010
- November 12, 2009
- October 8, 2009
- October 5, 2009
- September 17, 2009
- August 10, 2009
- August 6, 2009
- August 5, 2009
- June 3, 2009
- April 22, 2009
- February 24, 2009
- February 6, 2009
- December 8, 2008
- October 20, 2008
- June 5, 2008
- May 27, 2008
- May 20, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
